Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Sabre
SABR
$654M
| $5.75M | ﹤0.01% |
2,751,569
+28,047
| +1% | +$49.2K |
2014 Q4
46 quarters
|
|
2152
Enliven Therapeutics
ELVN
$3.24B
| $5.73M | ﹤0.01% |
112,972
+51,220
| +83% | +$2.17M |
2023 Q3
11 quarters
|
|
2153
Fox Factory Holding Corp
FOXF
$672M
| $5.73M | ﹤0.01% |
338,189
-16,488
| -5% | -$287K |
2016 Q3
39 quarters
|
|
2154
Invesco Taxable Municipal Bond ETF
BAB
$870M
| $5.73M | ﹤0.01% |
213,410
-1,136
| -0.5% | -$30.5K |
2013 Q2
52 quarters
|
|
2155
Varonis Systems
VRNS
$5.61B
| $5.72M | ﹤0.01% |
136,236
-11,534
| -8% | -$338K |
2016 Q3
39 quarters
|
|
2156
Butterfly Network
BFLY
$1.71B
| $5.7M | ﹤0.01% |
676,885
+270,689
| +67% | +$1.4M |
2025 Q1
5 quarters
|
|
2157
Warby Parker
WRBY
$3.04B
| $5.7M | ﹤0.01% |
187,826
+89,776
| +92% | +$2.22M |
2022 Q2
16 quarters
|
|
2158
PACS Group
PACS
$7.57B
| $5.68M | ﹤0.01% |
133,147
+55,060
| +71% | +$1.98M |
2024 Q2
8 quarters
|
|
2159
Tenable Holdings
TENB
$5.32B
| $5.67M | ﹤0.01% |
153,676
+2,524
| +2% | +$59.4K |
2020 Q3
23 quarters
|
|
2160
Weis Markets
WMK
$1.84B
| $5.65M | ﹤0.01% |
72,122
-5,766
| -7% | -$423K |
2013 Q2
52 quarters
|
|
2161
Fastly Inc
FSLY
$3.68B
| $5.65M | ﹤0.01% |
307,576
-583,686
| -65% | -$12.7M |
2020 Q2
24 quarters
|
|
2162
Eaton Vance Floating-Rate Income Trust
EFT
$282M
| $5.62M | ﹤0.01% |
520,407
+11,896
| +2% | +$129K |
2013 Q2
52 quarters
|
|
2163
Marten Transport
MRTN
$957M
| $5.61M | ﹤0.01% |
323,199
-37,022
| -10% | -$589K |
2013 Q2
52 quarters
|
|
2164
Colliers International
CIGI
$4.94B
| $5.59M | ﹤0.01% |
59,571
-317,533
| -84% | -$32M |
2013 Q2
52 quarters
|
|
2165
BlackRock Health Sciences Trust
BME
$606M
| $5.59M | ﹤0.01% |
130,083
-4,569
| -3% | -$182K |
2013 Q2
52 quarters
|
|
2166
Nektar Therapeutics
NKTR
$1.33B
| $5.57M | ﹤0.01% |
79,856
-487,602
| -86% | -$35.7M |
2013 Q2
52 quarters
|
|
2167
BlackBerry
BB
$4.94B
| $5.55M | ﹤0.01% |
438,870
+276,754
| +171% | +$1.93M |
2013 Q2
52 quarters
|
|
2168
Rogers Communications
RCI
$17.6B
| $5.55M | ﹤0.01% |
170,653
-593,321
| -78% | -$21.4M |
2013 Q2
52 quarters
|
|
2169
SELLAS Life Sciences
SLS
$1.95B
| $5.54M | ﹤0.01% |
375,342
-322,738
| -46% | -$2.23M |
2025 Q2
4 quarters
|
|
2170
StoneCo
STNE
$1.79B
| $5.49M | ﹤0.01% |
506,425
-30,947
| -6% | -$367K |
2019 Q2
28 quarters
|
|
2171
Payoneer
PAYO
$2.42B
| $5.48M | ﹤0.01% |
769,135
-64,332
| -8% | -$352K |
2021 Q3
19 quarters
|
|
2172
DELISTED
Nuvalent
NUVL
| $5.45M | ﹤0.01% |
44,164
-364,121
| -89% | -$39.2M |
2023 Q2
12 quarters
|
|
2173
Frontline
FRO
$12.7B
| $5.45M | ﹤0.01% |
156,532
-34,605
| -18% | -$1.27M |
2014 Q1
49 quarters
|
|
2174
Enovis
ENOV
$1.15B
| $5.41M | ﹤0.01% |
261,533
+41,490
| +19% | +$978K |
2013 Q2
52 quarters
|
|
2175
IDEAYA Biosciences
IDYA
$3.08B
| $5.41M | ﹤0.01% |
145,220
+34,108
| +31% | +$1.04M |
2021 Q3
19 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.